SOURCE: Cypress Bioscience, Inc.

September 18, 2008 06:30 ET

Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference

SAN DIEGO, CA--(Marketwire - September 18, 2008) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the UBS Global Life Sciences Conference on Tuesday, September 23, 2008.

The UBS conference is being held at the Grand Hyatt Hotel, New York, NY. Ms. Johnson is scheduled to present on Tuesday, September 23rd at 3:00 p.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at www.ibb.ubs.com (click on Conferences link).

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience, Inc.

Cypress Bioscience is committed to developing and commercializing pharmaceutical products and personalized medicine laboratory services that allow physicians to serve unmet medical needs. Cypress' strategy involves evaluating various other potential strategic transactions, including the potential acquisition of products, product candidates, technologies and companies, and other alternatives.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact
    Michael Hufford
    VP Corporate Development
    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact